| Tag | Content |
|---|
EnhancerAtlas ID | HS134-48019 | Organism | Homo sapiens | Tissue/cell | Mesendoderm | Coordinate | chr5:94775530-94776860 | Target genes | | | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| | | Number: 2 | ID | Chromosome | Start | End |
| GH05I095439 | chr5 | 94775603 | 94775864 | | GH05I095440 | chr5 | 94775961 | 94776190 |
| Enhancer Sequence | TTAACTTTAA ATAAAAGTGT TTTAATAACA TTAAAGGTTA AGTTTAGTCA GACACCGTGG 60
CACACACCTG TAGTCCCAGC TACCCAGGAG GCTGAGGCAA GCAGGATCGC TTGAACCCAG 120
GAGTTCGGGT TACAATGAGC TGTCATTGCA CCACTGCATG CCAGCCTGGA TGACAGAGCA 180
AGACCTGGTC TCTAAAAAAG TCTTTTAACA AAGGTTAAGG TTAACCTTTG TTTGGCTTGA 240
AGACCAGAAA ATTAGACACT ACAAGATTGA AGACAGCTAA TTTAAGAAAC ATCCACAGCA 300
GAGACTGGCA CAAGTTCTTT GAAAAGTGTC TCAGAGGTGC TGACAAGTCC TTTCAAGATT 360
CAAGATCAAC AAGAAGCTAT TGACTGGCTT CTCGGTCTAG CTGTGAGGCT TGAATATGGA 420
GATAATGCTG AAAAATACAA GGACTTAGTA CCTGATTATG CAAAAACTGC TGACAATGCA 480
ACTAAAAATG CAGAACCATT GATCAATTTG GATGTAAATA ATCCTGATGT TAAGGCTGGT 540
GTGAAGGCTA ACCTGCTTCA GATTCAATGT CATGACGATT ACCTGGTAAT GCCTAAGGCA 600
ATTCGAATTT TGGTTCAGGA GCACCTGACA GGATGCAGTT GCTAAGGCAA ATCAAACAGA 660
GGGTTTGCCT GTTGCTTTAG ACAAAATATT ATTGGTTTTG ATGCAGGAGA TGCAGTTCTT 720
AATGAAGCTG CTCAAATTCT GCAATTACTG CATATAGAAG AGCTCAGAGA GCTACAGACA 780
AAAATTAATG AAGCCATAGT AGCTGTTCAG ACAATTATTA CTGATCCAAG GACAGACCAC 840
AGACTGGGAA AAGTTGGAAG ATGAACACTT TAGGACTTCA GCTTCTCACC TATTTAGTAC 900
AACTGGGAAC CATGTCCACT TCTGGCATGT TTGAAAATCA AACGTCACAT TTTGCGGGGA 960
GGAATCCCAG AAAAGTGACT ATGTTCTAGT GCTTTTTTCT TTAATAAAGT TTAGGAAAGT 1020
AGGGGAAAAA AAAGAGCAGA GCTGCTGCAG GCCAGGGCCA CCTTCACTCG GGATACCTCT 1080
GTGGTTACCA GATGTCAATC ATGGAAAATG TGAGAGAGAA GAGAAGAGCA ATACTGAAAA 1140
AGTTTCCCCG TGCCACACCT ACTCGCAGGT GTCTTGGCAG GGAATCCAGG AGCAAATGCC 1200
TTCAAAACGC CAAGGTAATT CCGTCTCCAC CACCATCCTC ATTAGTAAAT TGAAACCCGA 1260
GACGATGGCT TTTATGTCAC CTCACTTGCC AAGATACAAT TAAAACCTGT CAAGACAGGT 1320
TGTCAAAATG 1330
|
| |
|
|
|
